Bausch Health Companies Inc. (BHC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 10.15 |
| Open | 10.30 |
| Bid | 9.86 x 1200 |
| Ask | 9.85 x 1400 |
| Day's Range | 9.52 - 10.41 |
| 52 Week Range | 7.80 - 32.54 |
| Volume | |
| Avg. Volume | 6,355,193 |
| Market Cap | 3.568B |
| Beta (5Y Monthly) | 1.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.27 |
| Earnings Date | Feb 22, 2022 - Feb 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 10, 2010 |
| 1y Target Est | 22.52 |
- Zacks
New Strong Sell Stocks for May 19th
ASX, CNMD, and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2022.
- CNW Group
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and disorders, today announced seven posters on behalf of XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride
- Bloomberg
ProFrac’s Oil Services Below-Range IPO Shows Market Still Idling
(Bloomberg) -- Oil services firm ProFrac Holding Corp. raised $288 million in an initial public offering, pricing its shares below a marketed range as new listings in the US continue to fall short of goals.Most Read from BloombergSony PlayStation Staff Fume Over CEO’s Abortion CommentsUkraine Latest: US Senator Delays Aid Vote; Russia Eyes BorderTerraform Again Halts Blockchain Behind UST Stablecoin, LunaMore Than $200 Billion Wiped Off Cryptocurrency Market in a DayCrypto Billionaires’ Vast For
